|
Volumn 22, Issue 1, 2012, Pages 34-39
|
American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: Revisited
|
Author keywords
benign prostatic hyperplasia; clinical practice guidelines; evidence based medicine; lower urinary tract symptoms
|
Indexed keywords
ALFUZOSIN;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOXAZOSIN;
DUTASTERIDE;
FINASTERIDE;
PHENOXYBENZAMINE;
PRAZOSIN;
PROSTATE SPECIFIC ANTIGEN;
STEROID 5ALPHA REDUCTASE INHIBITOR;
TAMSULOSIN;
TERAZOSIN;
AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX;
BLADDER NECK STENOSIS;
CYSTOSCOPY;
DIGITAL RECTAL EXAMINATION;
FOLLOW UP;
HOLMIUM LASER;
HUMAN;
LOWER URINARY TRACT SYMPTOM;
MEDICAL LITERATURE;
MEDICAL SOCIETY;
PHYSICAL EXAMINATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
PROSTATECTOMY;
PROTEIN BLOOD LEVEL;
REVIEW;
STENT;
TRANSURETHRAL ELECTROVAPORIZATION;
TRANSURETHRAL INCISION OF THE PROSTATE;
TRANSURETHRAL MICROWAVE THERMOTHERAPY;
TRANSURETHRAL NEEDLE ABLATION;
TRANSURETHRAL RESECTION;
URINALYSIS;
URODYNAMICS;
UROLOGY;
EUROPE;
EVIDENCE-BASED MEDICINE;
GUIDELINE ADHERENCE;
HUMANS;
LOWER URINARY TRACT SYMPTOMS;
MALE;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
PROSTATIC HYPERPLASIA;
QUALITY OF HEALTH CARE;
SOCIETIES, MEDICAL;
UNITED STATES;
UROLOGY;
|
EID: 83055198381
PISSN: 09630643
EISSN: 14736586
Source Type: Journal
DOI: 10.1097/MOU.0b013e32834d8e87 Document Type: Review |
Times cited : (25)
|
References (14)
|